Logo image of AMBI

AMBIPAR EMERGENCY RESPONSE (AMBI) Stock Fundamental Analysis

NYSEARCA:AMBI - NYSE Arca - KYG025321020 - Common Stock - Currency: USD

4.8  +0 (+0.1%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMBI. AMBI was compared to 84 industry peers in the Commercial Services & Supplies industry. AMBI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AMBI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AMBI had positive earnings in the past year.
AMBI had a positive operating cash flow in the past year.
In multiple years AMBI reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: AMBI reported negative operating cash flow in multiple years.
AMBI Yearly Net Income VS EBIT VS OCF VS FCFAMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 200M 400M

1.2 Ratios

AMBI's Return On Assets of 0.93% is in line compared to the rest of the industry. AMBI outperforms 51.19% of its industry peers.
AMBI has a Return On Equity (3.62%) which is comparable to the rest of the industry.
AMBI has a Return On Invested Capital of 9.19%. This is in the better half of the industry: AMBI outperforms 75.00% of its industry peers.
AMBI had an Average Return On Invested Capital over the past 3 years of 9.89%. This is in line with the industry average of 11.08%.
Industry RankSector Rank
ROA 0.93%
ROE 3.62%
ROIC 9.19%
ROA(3y)4.14%
ROA(5y)N/A
ROE(3y)26.2%
ROE(5y)N/A
ROIC(3y)9.89%
ROIC(5y)N/A
AMBI Yearly ROA, ROE, ROICAMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 20 30 40

1.3 Margins

The Profit Margin of AMBI (1.53%) is comparable to the rest of the industry.
The Operating Margin of AMBI (16.79%) is better than 85.71% of its industry peers.
AMBI has a Gross Margin of 17.67%. This is in the lower half of the industry: AMBI underperforms 77.38% of its industry peers.
Industry RankSector Rank
OM 16.79%
PM (TTM) 1.53%
GM 17.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMBI Yearly Profit, Operating, Gross MarginsAMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMBI is creating some value.
Compared to 1 year ago, AMBI has about the same amount of shares outstanding.
Compared to 1 year ago, AMBI has an improved debt to assets ratio.
AMBI Yearly Shares OutstandingAMBI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M 50M
AMBI Yearly Total Debt VS Total AssetsAMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.37, we must say that AMBI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AMBI (1.37) is worse than 69.05% of its industry peers.
AMBI has a debt to FCF ratio of 9.96. This is a negative value and a sign of low solvency as AMBI would need 9.96 years to pay back of all of its debts.
AMBI's Debt to FCF ratio of 9.96 is fine compared to the rest of the industry. AMBI outperforms 61.90% of its industry peers.
AMBI has a Debt/Equity ratio of 1.93. This is a high value indicating a heavy dependency on external financing.
AMBI has a Debt to Equity ratio of 1.93. This is in the lower half of the industry: AMBI underperforms 77.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 9.96
Altman-Z 1.37
ROIC/WACC1.13
WACC8.13%
AMBI Yearly LT Debt VS Equity VS FCFAMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

AMBI has a Current Ratio of 2.07. This indicates that AMBI is financially healthy and has no problem in meeting its short term obligations.
AMBI has a Current ratio of 2.07. This is in the better half of the industry: AMBI outperforms 69.05% of its industry peers.
AMBI has a Quick Ratio of 1.97. This is a normal value and indicates that AMBI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AMBI (1.97) is better than 79.76% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.97
AMBI Yearly Current Assets VS Current LiabilitesAMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500M 1B

More info and screens

1

3. Growth

3.1 Past

AMBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -138.69%.
AMBI shows a strong growth in Revenue. In the last year, the Revenue has grown by 53.72%.
EPS 1Y (TTM)-138.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.37%
Revenue 1Y (TTM)53.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%57.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMBI Yearly Revenue VS EstimatesAMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 500M 1B 1.5B 2B 2.5B

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.00, which means the current valuation is very expensive for AMBI.
The rest of the industry has a similar Price/Earnings ratio as AMBI.
AMBI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.86.
Industry RankSector Rank
PE 30
Fwd PE N/A
AMBI Price Earnings VS Forward Price EarningsAMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMBI indicates a rather cheap valuation: AMBI is cheaper than 94.05% of the companies listed in the same industry.
AMBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMBI is cheaper than 95.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.3
EV/EBITDA 4.48
AMBI Per share dataAMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMBI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMBIPAR EMERGENCY RESPONSE

NYSEARCA:AMBI (8/20/2025, 8:04:02 PM)

4.8

+0 (+0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.25%
Inst Owner Change-16.65%
Ins Owners1.68%
Ins Owner ChangeN/A
Market Cap266.06M
AnalystsN/A
Price TargetN/A
Short Float %0.3%
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30
Fwd PE N/A
P/S 0.46
P/FCF 5.3
P/OCF 3.72
P/B 1.09
P/tB N/A
EV/EBITDA 4.48
EPS(TTM)0.16
EY3.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.91
FCFY18.86%
OCF(TTM)1.29
OCFY26.89%
SpS10.43
BVpS4.41
TBVpS-2.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.62%
ROCE 12.09%
ROIC 9.19%
ROICexc 10.17%
ROICexgc 20.1%
OM 16.79%
PM (TTM) 1.53%
GM 17.67%
FCFM 8.68%
ROA(3y)4.14%
ROA(5y)N/A
ROE(3y)26.2%
ROE(5y)N/A
ROIC(3y)9.89%
ROIC(5y)N/A
ROICexc(3y)10.24%
ROICexc(5y)N/A
ROICexgc(3y)23.5%
ROICexgc(5y)N/A
ROCE(3y)12.99%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 9.96
Debt/EBITDA 3.23
Cap/Depr 43.69%
Cap/Sales 3.69%
Interest Coverage 4.15
Cash Conversion 49.01%
Profit Quality 566.61%
Current Ratio 2.07
Quick Ratio 1.97
Altman-Z 1.37
F-Score4
WACC8.13%
ROIC/WACC1.13
Cap/Depr(3y)141.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-138.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%57.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-143.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.34%
OCF growth 3YN/A
OCF growth 5YN/A